Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 January 2019 | Story Charlene Stanley | Photo Charlene Stanley
Michele Middle
Michelle Middle, CMO of Farmovs, looks forward to expanding their operations after the UFS acquired 100% shareholding in 2018.

In medical research, there are NO shortcuts.

The journey of a new medicine from lab to pharmacy shelf takes on average at least 10 years.

Michelle Middle’s journey from young medical graduate starting her first job at FARMOVS to becoming the company’s Chief Medical Officer, was more than twice that long. It was a journey that systematically and adequately equipped her to now Co-captain this flagship enterprise through its biggest challenge yet.

Michelle remembers how Farmovs started in 1974 as a research centre in the Department of Pharmacology. After graduating as medical doctor, she joined Farmovs in 1993, shortly before they moved to their current extensive facilities just south of the Sasol Library.

In 2000, international Clinical Research Organization (CRO) giant Parexel acquired a 70% shareholding, and the name changed to Farmovs-Parexel.

“Parexel really invested a lot in infrastructure and technology, bringing facilities here on par with the best in the world,” says Michelle.

Her own journey in medical research took her to George and later to the US and UK, where she held various international executive leadership positions in international companies.

When the UFS acquired a 100% shareholding in Farmovs earlier this year, she came full circle, as she returned to Bloemfontein to spearhead the expansion of patient studies in collaboration with the Faculty of Health Sciences.

“The opportunities we have here are really enormous,” says an excited Michelle.

“We are the only university in the country with this kind of infrastructure. Apart from our state-of-the-art bioanalytical lab, we also have facilities to accommodate close to 100 research participants. We now have 45 years’ experience in advanced medical research, plus established international clients. We can provide pharmaceutical companies with basically everything they need to develop new medicines.”

Another exciting development is that they are expanding their clinical-trial patient population next year from healthy individuals to people suffering from a host of chronic conditions.

“While they are part of our clinical trials, patients gain valuable insight in their own conditions. We also sometimes pick up underlying medical issues they were not even aware of,” says Michelle.

The 150 Farmovs staff members range from doctors and nurses, to technologists, medical writers, and managers. While not technically part of the university staff, they form a valued part of the Bloemfontein Campus community.

News Archive

School of Management: Guest lecturers
2006-09-05

School of Management
Guest lecturers – MBA Programme
Second semester 2006

For more information contact Minette at jacobsm.ekw@mail.uovs.ac.za
or Keneilwe at mokgks.ekw@mail.uovs.ac.za

 

Name

Short Description

Date

Time


Ton Vosloo

Renosi Mokate

Zingile Dingani

Velaphi Ratshefola

Operations Director: ABI

19 July

10h00-12h00

Ruud Heijblom

Netherlands

21 July

9h00- 13h00

Millard Arnold

Executive Director: Murray&Roberts

24 July

10h00-12h00

Mias de Klerk

Executive Consultant: Sasol

26 July

10h00-12h00

Laurie Dippenaar

Firstrand

2 Aug

10h00-12h00

Ton Vosloo

Chairman: Naspers

21 Aug

10h00-12h00

Mike Schussler Economist of the Year
25 Aug
  

Malose Kekana

Umsombomvy Youth Fund

29 Aug

10h00-12h00

Bahle Goba

Nokusa Consulting

31 Aug

14h00-16h00

Renosi Mokate

Deputy Governor: SA Reserve Bank

18 Sept

10h00-12h00

Errol Kruger

Registrar of Banks

19 Sept

10h00-12h00

Michael Pfaff

CEO: RMB

20 Sept

10h00-12h00

Danie Marx

Consultant

21 Sept

10h00-12h00

Zingile Dingani

Secretary to Parliament

2 October

10h00-12h00

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept